Overview
PEPS ranks this pair inside the Top 300 market-cap universe. That means Injective and PGOLD are liquid enough for an indexable comparison, with metrics refreshed on the hourly coin pipeline.
Quick winners
Full comparison
| Metric | INJ | PGOLD |
|---|---|---|
| Price | $5.01 | $1,856.75 |
| Market Cap | $490.41M | $78.78M |
| FDV | — | — |
| Volume 24h | $2.77M | $2.17 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 293.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | PGOLD |
|---|---|---|
| 1H | — | — |
| 24H | +2.04% | -0.10% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | PGOLD |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.07 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 67.00 |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across Injective and PGOLD, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | INJ | PGOLD |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
PGOLD
Pros and cons
Pros of Injective
- Higher ranking for Injective can translate into tighter spreads on major venues.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
- Injective typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Composite PEPS readings for Injective can surface clearer module agreement during trend phases.
Cons of Injective
- Regulatory or macro headlines can hit Injective harder simply because it is more visible.
- Indicator stacks on Injective may stay stretched longer than expected in strong trends.
- When dominance narratives fade, Injective can lag hotter rotation names.
Pros of PGOLD
- Narrative optionality around PGOLD can reprice quickly when catalysts appear.
- Diversifying versus Injective with PGOLD can change portfolio factor exposure.
- If technical momentum aligns, PGOLD may outperform on medium-term windows.
Cons of PGOLD
- Weaker market-cap standing may leave PGOLD more exposed to liquidity droughts.
- Trend failures on PGOLD often travel faster than on more established assets.
- Relative underperformance versus Injective can persist through entire market regimes.
- Smaller book depth versus large caps can increase slippage for PGOLD.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. Injective and PGOLD can alternate leadership as macro liquidity and narrative rotate.
AI summary
For readers asking which is “better”, the honest answer is conditional. Injective and PGOLD solve overlapping but not identical market jobs. On-chain and developer fields, when available, add slower-moving context beneath the tape. Missing fundamentals should be treated as unknown, not as zeros. If your thesis is long-term adoption, weight fundamentals and liquidity; if tactical, weight trend/momentum — and always define invalidation.
FAQ
Which is better, Injective or PGOLD?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or PGOLD?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and PGOLD.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.